Cargando…
Promoting transparency, accountability, and access through a multi-stakeholder initiative: lessons from the medicines transparency alliance
BACKGROUND: Barriers to expanding access to medicines include weak pharmaceutical sector governance, lack of transparency and accountability, inadequate attention to social services on the political agenda, and financing challenges. Multi-stakeholder initiatives such as the Medicines Transparency Al...
Autores principales: | Vian, Taryn, Kohler, Jillian C., Forte, Gilles, Dimancesco, Deirdre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5457587/ https://www.ncbi.nlm.nih.gov/pubmed/28588896 http://dx.doi.org/10.1186/s40545-017-0106-x |
Ejemplares similares
-
Increasing transparency and accountability in national pharmaceutical systems
por: Paschke, Anne, et al.
Publicado: (2018) -
The risk of corruption in public pharmaceutical procurement: how anti-corruption, transparency and accountability measures may reduce this risk
por: Kohler, Jillian Clare, et al.
Publicado: (2020) -
Disclosure, transparency, and accountability: a qualitative survey of public sector pharmaceutical committee conflict of interest policies in the World Health Organization South-East Asia Region
por: Grundy, Quinn, et al.
Publicado: (2022) -
Anti-corruption, transparency and accountability in health: concepts, frameworks, and approaches
por: Vian, Taryn
Publicado: (2020) -
Promoting anti-corruption, transparency and accountability to achieve universal health coverage
por: Koller, Theadora, et al.
Publicado: (2020)